ClinicalTrials.govpublic full text
AI Chatbot-Enabled ePRO Symptom Monitoring and Self-Management for Early Cardiovascular-Kidney-Metabolic Syndrome
cardiovascular kidney metabolic syndrome, artificial intelligence, chatbot, electronic patient-reported outcomes, patient activation, randomized controlled trial, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995199
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.